4.7 Review

Ubiquitin-specific protease 14 is a new therapeutic target for the treatment of diseases

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 236, 期 5, 页码 3396-3405

出版社

WILEY
DOI: 10.1002/jcp.30124

关键词

DUBs; infection; neurodegenerative diseases; the ubiquitin– proteasome system; tumorigenesis; USP14

资金

  1. National Natural Science Foundation [81800006]

向作者/读者索取更多资源

USP14 is a ubiquitin-specific protease associated with the proteasome and plays crucial roles in cellular functions, viral infection, inflammatory responses, neurodegenerative diseases, and tumorigenesis. It appears to have a dual function in regulating intracellular proteolysis, inhibiting degradation of ubiquitinated proteins while also promoting protein degradation via proteasome activation. Additionally, USP14 is involved in the regulation of autophagy, suggesting a key role in intracellular proteolytic pathways.
Ubiquitin-specific protease 14 (USP14) is a ubiquitin-specific protease that is associated with the proteasome and plays important roles in cellular functions, viral infection, inflammatory responses, neurodegenerative diseases, and tumorigenesis. USP14 appears to have a dual function in regulating intracellular proteolytic degradation. USP14 impedes degradation of ubiquitinated proteins by removing ubiquitin chains from its substrates, while it could promote protein degradation via increasing proteasome activation. Increasing evidence has shown that USP14 is also involved in the regulation of autophagy. Thus, USP14 might act as a key regulator in two major intracellular proteolytic pathways: the ubiquitin-proteasome system (UPS) and autophagy. The important roles of USP14 in multiple diseases have encouraged the development of clinically viable USP14 antagonists. This review summarizes the current state of knowledge about the regulation of USP14 expression, activity, and its functions in physiological and pathological processes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据